Skip to main content
Erschienen in: Dysphagia 6/2018

21.05.2018 | Original Article

Drooling in Parkinson’s Disease: Evidence of a Role for Divided Attention

verfasst von: Hannah Reynolds, Nick Miller, Richard Walker

Erschienen in: Dysphagia | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Drooling is a frequently reported symptom in Parkinson’s Disease (PD) with significant psychosocial impact and negative health consequences including silent aspiration of saliva with the associated risk of respiratory infections. It is suggested that in PD drooling is associated with inefficient oropharyngeal swallowing which reduces the effective clearance of saliva rather than hyper-salivation. This is compounded by unintended mouth opening and flexed posture increasing anterior loss of saliva. It is reported to occur most frequently during cognitively distracting concurrent tasks suggesting an impact from divided attention in a dual-task situation. However, this supposition has not been systematically examined. This study assessed whether frequency of saliva swallows reduced, and drooling severity and frequency increased, when people with PD engaged in a cognitively distracting task. 18 patients with idiopathic PD reporting daytime drooling on the Unified Parkinson’s Disease Rating Scale (UPDRS) were recruited. They completed the Radboud Oral Motor Inventory for PD saliva questionnaire and the Montreal Cognitive Assessment. UPDRS drooling score, disease stage, duration, gender, and age were recorded. Swallow frequency and drooling severity and frequency were measured at rest and during a distracting computer-based language task. There was no significant difference between drooling severity at rest and during distraction (Wilcoxon signed rank test z = − 1.724, p = 0.085). There was a significant difference between at rest and distraction conditions for both drooling frequency (Wilcoxon signed rank test z = − 2.041, p = 0.041) and swallow frequency (Wilcoxon signed rank test z = − 3.054, p = 0.002). Participants swallowed less frequently and drooled more often during the distraction task. The frequency of saliva swallows and drooling are affected by divided attention in a dual-task paradigm. Further studies are needed to explore the exact role of attention in saliva management and the clinical applications in assessment and treatment.
Literatur
1.
Zurück zum Zitat Kalf JG, Bloem BR, Munneke M. Diurnal and nocturnal drooling in Parkinson’s disease. J Neurol. 2012;259(1):119–23.CrossRef Kalf JG, Bloem BR, Munneke M. Diurnal and nocturnal drooling in Parkinson’s disease. J Neurol. 2012;259(1):119–23.CrossRef
2.
Zurück zum Zitat Srivanitchapoom P, Pandey S, Hallett M. Drooling in Parkinson’s disease: a review. Parkinsonism Relat Disord. 2014;20(11):1109–18.CrossRef Srivanitchapoom P, Pandey S, Hallett M. Drooling in Parkinson’s disease: a review. Parkinsonism Relat Disord. 2014;20(11):1109–18.CrossRef
3.
Zurück zum Zitat Kalf J, Smit A, Bloem B, Zwarts M, Munneke M. Impact of drooling in Parkinson’s disease. J Neurol. 2007;2007(254):1227–32.CrossRef Kalf J, Smit A, Bloem B, Zwarts M, Munneke M. Impact of drooling in Parkinson’s disease. J Neurol. 2007;2007(254):1227–32.CrossRef
4.
Zurück zum Zitat Leibner J, Ramjit A, Sedig L, Dai Y, Wu SS, Jacobson C, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH. The impact of and the factors associated with drooling in Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(7):475–7.CrossRef Leibner J, Ramjit A, Sedig L, Dai Y, Wu SS, Jacobson C, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH. The impact of and the factors associated with drooling in Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(7):475–7.CrossRef
5.
Zurück zum Zitat Nobrega AC, Rodrigues B, Melo A. Is silent aspiration a risk factor for respiratory infection in Parkinson’s disease patients? Parkinsonism Relat Disord. 2008;14:643–8. Nobrega AC, Rodrigues B, Melo A. Is silent aspiration a risk factor for respiratory infection in Parkinson’s disease patients? Parkinsonism Relat Disord. 2008;14:643–8.
7.
Zurück zum Zitat Kalf JG, Munneke M, van den Engel-Hoek L, de Swart BJ, Borm GF, Bloem BR, Zwarts MJ. Pathophysiology of diurnal drooling in Parkinson’s disease. Mov Disord. 2011;26(9):1670–6.CrossRef Kalf JG, Munneke M, van den Engel-Hoek L, de Swart BJ, Borm GF, Bloem BR, Zwarts MJ. Pathophysiology of diurnal drooling in Parkinson’s disease. Mov Disord. 2011;26(9):1670–6.CrossRef
8.
Zurück zum Zitat Evatt ML, Chaudhuri K, Chou KL, Cubo E, Hinson V, Kompoliti K, Yang C, Poewe W, Rascol O, Sampaio C, Stebbins GT. Dysautonomia rating scales in Parkinson’s disease: sialorrhea, dysphagia, and constipation—critique and recommendations by movement disorders task force on rating scales for Parkinson’s disease. Mov Disord. 2009;24(5):635–46.CrossRef Evatt ML, Chaudhuri K, Chou KL, Cubo E, Hinson V, Kompoliti K, Yang C, Poewe W, Rascol O, Sampaio C, Stebbins GT. Dysautonomia rating scales in Parkinson’s disease: sialorrhea, dysphagia, and constipation—critique and recommendations by movement disorders task force on rating scales for Parkinson’s disease. Mov Disord. 2009;24(5):635–46.CrossRef
9.
Zurück zum Zitat Kalf JG, Borm GF, de Swart BJ, Bloem BR, Zwarts MJ, Munneke M. Reproducibility and validity of patient-rated assessment of speech, swallowing, and saliva control in Parkinson’s disease. Arch Phys Med Rehabil. 2011;92(7):1152–8.CrossRef Kalf JG, Borm GF, de Swart BJ, Bloem BR, Zwarts MJ, Munneke M. Reproducibility and validity of patient-rated assessment of speech, swallowing, and saliva control in Parkinson’s disease. Arch Phys Med Rehabil. 2011;92(7):1152–8.CrossRef
10.
Zurück zum Zitat Pehlivan M, Yüceyar N, Ertekin C, Çelebi G, Ertaş M, Kalayci T, Aydoğdu I. An electronic device measuring the frequency of spontaneous swallowing: digital phagometer. Dysphagia. 1996;11(4):259–64.CrossRef Pehlivan M, Yüceyar N, Ertekin C, Çelebi G, Ertaş M, Kalayci T, Aydoğdu I. An electronic device measuring the frequency of spontaneous swallowing: digital phagometer. Dysphagia. 1996;11(4):259–64.CrossRef
11.
Zurück zum Zitat Hyson HC, Johnson AM, Jog MS. Sublingual atropine for sialorrhea secondary to Parkinsonism: a pilot study. Mov Disord. 2002;17(6):1318–20.CrossRef Hyson HC, Johnson AM, Jog MS. Sublingual atropine for sialorrhea secondary to Parkinsonism: a pilot study. Mov Disord. 2002;17(6):1318–20.CrossRef
12.
Zurück zum Zitat Arbouw M, Movig K, Koopmann M, Poels P, Guchelaar H, Egberts T, Neef C, van Vugt J. Glycopyrrolate for sialorrhea in Parkinson disease; a randomized, double-blind, crossover trial. Neurology. 2010;74:1203–7.CrossRef Arbouw M, Movig K, Koopmann M, Poels P, Guchelaar H, Egberts T, Neef C, van Vugt J. Glycopyrrolate for sialorrhea in Parkinson disease; a randomized, double-blind, crossover trial. Neurology. 2010;74:1203–7.CrossRef
13.
Zurück zum Zitat Perez-Lloret S, Nègre-Pagès L, Ojero-Senard A, Damier P, Destee A, Tison F, Merello M, Rascol O. Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort. Eur J Neurol. 2012;19(1):28–37.CrossRef Perez-Lloret S, Nègre-Pagès L, Ojero-Senard A, Damier P, Destee A, Tison F, Merello M, Rascol O. Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort. Eur J Neurol. 2012;19(1):28–37.CrossRef
14.
Zurück zum Zitat Marks L, Turner K, O’Sullivan J, Deighton B, Lees A. Drooling in Parkinson’s disease: a novel speech and language therapy intervention. Int J Lang Commun Disord. 2001;36:282–7.CrossRef Marks L, Turner K, O’Sullivan J, Deighton B, Lees A. Drooling in Parkinson’s disease: a novel speech and language therapy intervention. Int J Lang Commun Disord. 2001;36:282–7.CrossRef
15.
Zurück zum Zitat McNaney R, Lindsay S, Ladha K, Ladha C, Schofield G, Ploetz T, Hammerla N, Jackson D, Walker R, Miller N, Olivier P. Cueing for drooling in Parkinson’s disease. In: Proceedings of the SIGCHI conference on Human Factors in Computing Systems. ACM; 2011. pp. 619–622. McNaney R, Lindsay S, Ladha K, Ladha C, Schofield G, Ploetz T, Hammerla N, Jackson D, Walker R, Miller N, Olivier P. Cueing for drooling in Parkinson’s disease. In: Proceedings of the SIGCHI conference on Human Factors in Computing Systems. ACM; 2011. pp. 619–622.
16.
Zurück zum Zitat South AR, Somers SM, Jog MS. Gum chewing improves swallow frequency and latency in Parkinson patients: a preliminary study. Neurology. 2010;74(15):1198–202.CrossRef South AR, Somers SM, Jog MS. Gum chewing improves swallow frequency and latency in Parkinson patients: a preliminary study. Neurology. 2010;74(15):1198–202.CrossRef
17.
Zurück zum Zitat Sarra N, Siderowf A, Duda J, Ten Have T, Colcher A, Horn S, Moberg P, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D. Montreal cognitive assessment performance in patients with Parkinson’s Disease with “Normal” global cognition according to mini mental state examination score. J Am Geriatr Soc. 2009;57(2):304–8.CrossRef Sarra N, Siderowf A, Duda J, Ten Have T, Colcher A, Horn S, Moberg P, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D. Montreal cognitive assessment performance in patients with Parkinson’s Disease with “Normal” global cognition according to mini mental state examination score. J Am Geriatr Soc. 2009;57(2):304–8.CrossRef
18.
Zurück zum Zitat Kudlicka A, Clare L, Hindle JV. Pattern of executive impairment in mild to moderate Parkinson’s disease. Dement Geriatr Cogn Disord. 2013;36(1–2):50–66.CrossRef Kudlicka A, Clare L, Hindle JV. Pattern of executive impairment in mild to moderate Parkinson’s disease. Dement Geriatr Cogn Disord. 2013;36(1–2):50–66.CrossRef
19.
Zurück zum Zitat Stojmenovic GM, Stefanova E, Stojkovic T, Tomic A, Markovic V, Lukic MJ, Kresojevic N, Stankovic I, Kostic V. Attentional flexibility deficits in Parkinson’s disease patients with freezing of gait. Mov Disord. 2014;29:S354–5. Stojmenovic GM, Stefanova E, Stojkovic T, Tomic A, Markovic V, Lukic MJ, Kresojevic N, Stankovic I, Kostic V. Attentional flexibility deficits in Parkinson’s disease patients with freezing of gait. Mov Disord. 2014;29:S354–5.
20.
Zurück zum Zitat Dromey C, Jarvis E, Sondrup S, Nissen S, Foreman KB, Dibble LE. Bidirectional interference between speech and postural stability in individuals with Parkinson’s disease. Int J Speech Lang Pathol. 2010;12(5):446–54.CrossRef Dromey C, Jarvis E, Sondrup S, Nissen S, Foreman KB, Dibble LE. Bidirectional interference between speech and postural stability in individuals with Parkinson’s disease. Int J Speech Lang Pathol. 2010;12(5):446–54.CrossRef
21.
Zurück zum Zitat Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008;23(3):329–42.CrossRef Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008;23(3):329–42.CrossRef
22.
Zurück zum Zitat Muralidharan V, Balasubramani PP, Chakravarthy S, Gilat M, Lewis SJ, Moustafa AA. A neurocomputational model of the effect of cognitive load on freezing of gait in parkinson’s disease. Front Hum Neurosci. 2016;10:649.PubMed Muralidharan V, Balasubramani PP, Chakravarthy S, Gilat M, Lewis SJ, Moustafa AA. A neurocomputational model of the effect of cognitive load on freezing of gait in parkinson’s disease. Front Hum Neurosci. 2016;10:649.PubMed
23.
Zurück zum Zitat Brodsky MB, Abbott KV, McNeil MR, Palmer CV, Grayhack JP, Martin-Harris B. Effects of divided attention on swallowing in persons with idiopathic Parkinson’s disease. Dysphagia. 2012;27(3):390–400.CrossRef Brodsky MB, Abbott KV, McNeil MR, Palmer CV, Grayhack JP, Martin-Harris B. Effects of divided attention on swallowing in persons with idiopathic Parkinson’s disease. Dysphagia. 2012;27(3):390–400.CrossRef
24.
Zurück zum Zitat Troche MS, Okun MS, Rosenbek JC, Altmann LJ, Sapienza CM. Attentional resource allocation and swallowing safety in Parkinson’s disease: a dual task study. Parkinsonism Relat Disord. 2014;20(4):439–43.CrossRef Troche MS, Okun MS, Rosenbek JC, Altmann LJ, Sapienza CM. Attentional resource allocation and swallowing safety in Parkinson’s disease: a dual task study. Parkinsonism Relat Disord. 2014;20(4):439–43.CrossRef
25.
Zurück zum Zitat Rana A, Khondker S, Kabir A, Owalia A, Emre M. Impact of cognitive dysfunction on drooling in Parkinson’s disease. Eur J Neurol. 2013;70(1–2):42–5.CrossRef Rana A, Khondker S, Kabir A, Owalia A, Emre M. Impact of cognitive dysfunction on drooling in Parkinson’s disease. Eur J Neurol. 2013;70(1–2):42–5.CrossRef
26.
Zurück zum Zitat Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.CrossRef Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.CrossRef
27.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–4.CrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–4.CrossRef
28.
Zurück zum Zitat Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–42.CrossRef Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–42.CrossRef
29.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRef Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRef
30.
Zurück zum Zitat Gernsbacher MA, Faust ME. The mechanism of suppression: a component of general comprehension skill. J Exp Psychol Learn Mem Cogn. 1991;17:245.CrossRef Gernsbacher MA, Faust ME. The mechanism of suppression: a component of general comprehension skill. J Exp Psychol Learn Mem Cogn. 1991;17:245.CrossRef
31.
Zurück zum Zitat Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3(2):73–8.CrossRef Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3(2):73–8.CrossRef
32.
Zurück zum Zitat Banerjee KJ, Glasson C, O’Flaherty SJ. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol. 2006;48(11):883–7.CrossRef Banerjee KJ, Glasson C, O’Flaherty SJ. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol. 2006;48(11):883–7.CrossRef
33.
Zurück zum Zitat Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in Parkinsonism. Mov Disord. 2003;18(6):685–8.CrossRef Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in Parkinsonism. Mov Disord. 2003;18(6):685–8.CrossRef
34.
Zurück zum Zitat Ondo WG, Hunter C, Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease. Neurology. 2004;62(1):37–40.CrossRef Ondo WG, Hunter C, Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease. Neurology. 2004;62(1):37–40.CrossRef
36.
Zurück zum Zitat Santamato A, Panza F, Solfrizzi V, Russo A, Frisardi V, Megna M, Ranieri M, Fiore P. Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia. J Rehabil Med. 2009;41(8):639–45.CrossRef Santamato A, Panza F, Solfrizzi V, Russo A, Frisardi V, Megna M, Ranieri M, Fiore P. Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia. J Rehabil Med. 2009;41(8):639–45.CrossRef
37.
Zurück zum Zitat Norman DA, Shallice T. Attention to action. In: Consciousness and self-regulation. Springer, Berlin; 1986. pp. 1–18. Norman DA, Shallice T. Attention to action. In: Consciousness and self-regulation. Springer, Berlin; 1986. pp. 1–18.
38.
Zurück zum Zitat Wu T, Liu J, Zhang H, Hallett M, Zheng Z, Chan P. Attention to automatic movements in Parkinson’s disease: modified automatic mode in the striatum. Cereb Cortex. 2015;25(10):3330–42.CrossRef Wu T, Liu J, Zhang H, Hallett M, Zheng Z, Chan P. Attention to automatic movements in Parkinson’s disease: modified automatic mode in the striatum. Cereb Cortex. 2015;25(10):3330–42.CrossRef
39.
Zurück zum Zitat LaPointe LL, Stierwalt JA, Maitland CG. Talking while walking: cognitive loading and injurious falls in Parkinson’s disease. Int J Speech Lang Pathol. 2010;12(5):455–9.CrossRef LaPointe LL, Stierwalt JA, Maitland CG. Talking while walking: cognitive loading and injurious falls in Parkinson’s disease. Int J Speech Lang Pathol. 2010;12(5):455–9.CrossRef
40.
Zurück zum Zitat Nieuwhof F, Bloem BR, Reelick MF, Aarts E, Maidan I, Mirelman A, Hausdorff JM, Toni I, Helmich RC. Impaired dual tasking in Parkinson’s disease is associated with reduced focusing of cortico-striatal activity. Brain. 2017;140(5):1384–98.CrossRef Nieuwhof F, Bloem BR, Reelick MF, Aarts E, Maidan I, Mirelman A, Hausdorff JM, Toni I, Helmich RC. Impaired dual tasking in Parkinson’s disease is associated with reduced focusing of cortico-striatal activity. Brain. 2017;140(5):1384–98.CrossRef
41.
Zurück zum Zitat Clark JP, Adams SG, Dykstra AD, Moodie S, Jog M. Loudness perception and speech intensity control in Parkinson’s disease. J Commun Disord. 2014;51:1–12.CrossRef Clark JP, Adams SG, Dykstra AD, Moodie S, Jog M. Loudness perception and speech intensity control in Parkinson’s disease. J Commun Disord. 2014;51:1–12.CrossRef
42.
Zurück zum Zitat Parveen S. Comparison of self and proxy ratings for motor performance of individuals with Parkinson disease. Brain Cogn. 2016;103:62–9.CrossRef Parveen S. Comparison of self and proxy ratings for motor performance of individuals with Parkinson disease. Brain Cogn. 2016;103:62–9.CrossRef
43.
Zurück zum Zitat Noble E, Jones D, Miller N. Patient reported changes to swallowing in Parkinson’s disease. Int J Ther Rehabil. 2015;22(12):573–81.CrossRef Noble E, Jones D, Miller N. Patient reported changes to swallowing in Parkinson’s disease. Int J Ther Rehabil. 2015;22(12):573–81.CrossRef
44.
Zurück zum Zitat Parker C, Power M, Hamdy S, Bowen A, Tyrrell P, Thompson DG. Awareness of dysphagia by patients following stroke predicts swallowing performance. Dysphagia. 2004;19(1):28–35.CrossRef Parker C, Power M, Hamdy S, Bowen A, Tyrrell P, Thompson DG. Awareness of dysphagia by patients following stroke predicts swallowing performance. Dysphagia. 2004;19(1):28–35.CrossRef
45.
Zurück zum Zitat De Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525–35.CrossRef De Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525–35.CrossRef
46.
Zurück zum Zitat Jenkinson C, Fitzpatrick RAY, Peto VIV, Greenhall R, Hyman N. The Parkinson’s disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26(5):353–7.CrossRef Jenkinson C, Fitzpatrick RAY, Peto VIV, Greenhall R, Hyman N. The Parkinson’s disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26(5):353–7.CrossRef
47.
Zurück zum Zitat McCaig CM, Adams SG, Dykstra AD, Jog M. Effect of concurrent walking and interlocutor distance on conversational speech intensity and rate in Parkinson’s disease. Gait Posture. 2016;43:132–6.CrossRef McCaig CM, Adams SG, Dykstra AD, Jog M. Effect of concurrent walking and interlocutor distance on conversational speech intensity and rate in Parkinson’s disease. Gait Posture. 2016;43:132–6.CrossRef
48.
Zurück zum Zitat Heinzel S, Maechtel M, Hasmann SE, Hobert MA, Heger T, Berg D, Maetzler W. Motor dual-tasking deficits predict falls in Parkinson’s disease: a prospective study. Parkinsonism Relat Disord. 2016;26:73–7.CrossRef Heinzel S, Maechtel M, Hasmann SE, Hobert MA, Heger T, Berg D, Maetzler W. Motor dual-tasking deficits predict falls in Parkinson’s disease: a prospective study. Parkinsonism Relat Disord. 2016;26:73–7.CrossRef
49.
Zurück zum Zitat Strouwen C, Molenaar EA, Keus SH, Münks L, Heremans E, Vandenberghe W, Bloem BR, Nieuwboer A. Are factors related to dual-task performance in people with Parkinson’s disease dependent on the type of dual task? Parkinsonism Relat Disord. 2016;23:23–30.CrossRef Strouwen C, Molenaar EA, Keus SH, Münks L, Heremans E, Vandenberghe W, Bloem BR, Nieuwboer A. Are factors related to dual-task performance in people with Parkinson’s disease dependent on the type of dual task? Parkinsonism Relat Disord. 2016;23:23–30.CrossRef
Metadaten
Titel
Drooling in Parkinson’s Disease: Evidence of a Role for Divided Attention
verfasst von
Hannah Reynolds
Nick Miller
Richard Walker
Publikationsdatum
21.05.2018
Verlag
Springer US
Erschienen in
Dysphagia / Ausgabe 6/2018
Print ISSN: 0179-051X
Elektronische ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-018-9906-7

Weitere Artikel der Ausgabe 6/2018

Dysphagia 6/2018 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.